ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P901. A total of 4 filers reported holding ASCENDIS PHARMA A S in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $644,000 | -22.8% | 50 | 0.0% | 0.02% | -22.6% |
| Q4 2020 | $834,000 | -70.3% | 50 | -72.5% | 0.03% | -81.8% |
| Q3 2020 | $2,809,000 | +4.3% | 182 | 0.0% | 0.17% | -7.6% |
| Q2 2020 | $2,692,000 | +44.4% | 182 | +35.8% | 0.18% | +13.6% |
| Q4 2019 | $1,864,000 | -5.1% | 134 | -34.3% | 0.16% | -10.0% |
| Q3 2019 | $1,965,000 | -16.4% | 204 | 0.0% | 0.18% | -15.9% |
| Q2 2019 | $2,350,000 | – | 204 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 54,800 | $5,875,656 | 0.02% |
| SIMPLEX TRADING, LLC | 60,000 | $6,433 | 0.01% |
| JANE STREET GROUP, LLC | 40,700 | $4,363,854 | 0.00% |
| JPMORGAN CHASE & CO | 75,000 | $8,042,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |